Fontan术后相关肝病:静脉淤血混杂MR弹性成像纤维化分期
MRE肝硬度与Ishak评分、Metavir评分、%SR染色及CHFS评分均无统计学显著相关。
要点
- Fontan术后患者MRE肝硬度与活检纤维化分期无显著相关,解读时需警惕静脉淤血影响。
- MRE肝硬度随时间的持续上升可能反映肝健康变化,可用于纵向随访。
- 评估Fontan相关肝病时,不宜仅凭MRE肝硬度诊断或分期纤维化。
诊断标准与关键数值
- MRE肝硬度与Ishak评分、Metavir评分、%SR染色及CHFS评分均无统计学显著相关。
临床应用与阅片要点
- Fontan术后患者行MRE检查时,肝硬度升高不一定代表纤维化进展,需结合临床静脉淤血状态综合判断。
- 对Fontan患者可定期复查MRE,利用肝硬度纵向变化趋势辅助随访肝健康。
- 报告MRE结果时应提示静脉淤血可能影响纤维化分期的准确性。
局限性
- 单中心回顾性设计,结果外推需谨慎。
- 未明确报告设备/序列细节及参考标准的可重复性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To compare targeted and global liver stiffness measured by magnetic resonance elastography (MRE) with liver biopsy in patients who have undergone the Fontan procedure, and to assess the relationship between liver stiffness and fibrosis stage.
MATERIALS AND METHODS: Targeted and global liver stiffness was compared with a quantification of liver fibrosis measured by percentage of Sirius Red (%SR) staining of biopsy samples. MRE values were compared with three other biopsy-scoring methods: Ishak, Scheuer/Ludwig-Batts/Metavir, and congestive hepatic fibrosis score (CHFS). Additionally, in patients who had two or more MRE studies, global liver stiffness was compared for longitudinal assessment.
RESULTS: Thirty-four patients were included in the study, with a mean age of 16.2 years. There was no statistically significant correlation between MRE-derived liver stiffness and Ishak score, Metavir score, %SR staining, and CHFS score. Twenty patients had multiple MRE studies, with a mean age of 16.5 years, and these showed a statistically significant increase in mean liver stiffness from 3.72 to 4.68 (26% increase) within an average period of 24 months.
CONCLUSIONS: The lack of correlation of liver stiffness with fibrosis stage observed in this study indicates that the effects of venous congestion in Fontan patients can confound the use of liver stiffness as a biomarker for fibrosis as assessed by percentage of SR staining, Ishak score, Metavir score, and CHFS score. These results provide motivation for further development of magnetic resonance imaging-based biomarkers to increase the specificity in the assessment of Fontan-associated liver disease. A steady increase in liver stiffness observed in these patients may be useful for longitudinal follow-up of liver health.
引用
- Serai, Tsitsiou, Wilkins, et al. MR elastography-based staging of liver fibrosis in Fontan procedure associated liver disease is confounded by effects of venous congestion. Clin Radiol. 2022. PMID: 35940927. doi:10.1016/j.crad.2022.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。